Selective activation of postsynaptic 5-HT(1A) receptors induces rapid antidepressant response

Neuropsychopharmacology

Volumn 16, Issue 5, 1997, Pages 333-338

  Blier, Pierre ^a   Bergeron, Richard ^a   Montigny, Claude de ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT(1A) agonist; major depression; pindolol; selective serotonin reuptake inhibitors; tricyclice antidepressants

Indexed keywords

BUSPIRONE; DESIPRAMINE; FLUVOXAMINE; PAROXETINE; PINDOLOL; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRIMIPRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BUSPIRONE; DEPRESSIVE DISORDER; DESIPRAMINE; DRUG SYNERGISM; FEMALE; FLUVOXAMINE; HUMANS; MALE; PINDOLOL; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; TRIMIPRAMINE;

EID: 0031005410     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00242-4     Document Type: Article

References (25)

1. Artigas F, Perez V, Alvarez E (1994): Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatr 51: 248-251
2. 1A antagonists. Trends NeuroSci 19:378-383
3. Bailly D (1996): The role of β-adrenoceptor blockers in the treatment of psychiatric disorders. CNS Drugs 5:115-136
4. Blier P, Bergeron R (1995): Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222
5. Blier P, Bergeron R (1996): Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: Preliminary findings. Int Clin Psychopharmacol 11:37-44
6. Blier P, Curet O, Chaput Y, de Montigny C (1991): Tandospirone and its metabolite l-(2-pyrimidinyl) piperazine (1-PP): II-Effects of acute 1-PP and long-term administration of tandospirane on noradrenergic neurotransmission. Neuropharmacology 30:691-701
7. Blier P, de Montigny C (1983): Electrophysiological studies on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270-1278
8. 1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse 1:470-480
9. Blier P, de Montigny C (1994): Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226
10. De-Bree H, Van-der-Schoot JB, Post LC (1983): Fluvoxamine maleate: Disposition in man. Eur J Drug Metab Pharmacokinet 8:175-179
11. 1A receptors: A future direction in the pharmacotherapy of affective disorders? In Meltzer HY, Nerozzi D (eds), Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders, Amsterdam, Elsevier, pp 99-104
12. de Montigny C, Chaput Y, Blier P (1993): Classical and novel targets for antidepressant drugs. Intl Acad Biomed and Drug Res 5:8-17
13. 1A agonist, on the firing of serotonergic dorsal raphe neurons in the rat brain slice. Soc Neurosci Abst 13:1649
14. Godbout R, Chaput Y, Blier P, de Montigny C (1991): Tandospirone and its metabolite l-(2-pyrimidinyl) piperazine: I - Effects of acute and long-term administration of tandospirone on serotonergic neurotransmission. Neuropharmacology 30:679-690
15. Hyttel I (1982): Citalopram-pharmacological profile of a specific serotonin reuptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatr 6:277-295
16. Isaac MT, Tome MB, Harte R (1996): Serotonergic autoreceptor blockade in the reduction of antidepressant latency: A controlled trial. Am Psychiatr Assoc Abstracts 149:154
17. Lund J, Thayssen P, Mengel H (1982): Paroxetine: Pharmaco-kinetics and cardiovascular effects after oral and intra-venous single doses in man. Acta Pharmacol Toxicol (Copenh) 51:351-357
18. Nemeroff CB, DeVane CL, Pollock BG (1996): Newer antidepressants and the cytochrome P450 system. Am J Psychiatr 153:311-320
19. Olivier B, Tulp MTM, Mos J (1991): Serotonergic receptors in anxiety and aggression: Evidence from animal pharmacology. Human Psychopharmacol 6:73-78
20. Ono S, Tsutsui M, Gonzalez FJ, Satoh T, Masubuchi Y, Horie T, Suzuki T, Narimatsu S (1995): Oxidative metabolism of bunitrolol by complementary DNA expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus. Pharmacogenetics 5:97-102
21. Price LH, Goddard AW, Barer LC, Goodman WK (1995): Pharmacological challenges in anxiety disorders. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress, New York, Raven Press, pp 1311-1321
22. Robinson DS, Rickel K, Feighner J (1990): Clinical effects of the 5-HT-1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 10:675-765
23. 1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349-360
24. Scuvée-Moreau J, Dresse A (1979): Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons in the rat. Eur J Pharmacol 57:219-225
25. Wagner W, Zabomy BA, Gray TE (1995): Fluvoxamine: A review of its safety profile in world-wide studies. Intl Clin Psychopharmacol 9:223-227